In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows.
New Drug Provides Relief for Resistant Epilepsy Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Renovus Capital Partners ("Renovus") is pleased to announce a majority investment in Thomas J Paul, Inc. ("TJP" or "the Company"). Based in.